It's about time.

For too long, people living with Crohn's disease and ulcerative colitis have lost precious time.

Time waiting for a diagnosis. Time cycling through treatments that don't work. Time spent in pain, in hospital beds, and away from the people and moments that matter most.

It's about time we changed that.

Today, a new era of inflammatory bowel disease (IBD) care is within reach. Through groundbreaking advances in precision medicine, researchers can begin to predict which treatments will work best for each individual patient, helping people get the right care sooner and avoid the devastating cycle of trial and error. Crohn's and Colitis Canada's IBD Precision Medicine Research Program is leading this transformation, and with your support, we can bring the next breakthrough closer.

Help fund the next breakthrough.

Donate now →

Introducing the IBD Precision Medicine Research Program

Crohn's and Colitis Canada is launching Canada's first national research initiative dedicated to advancing precision medicine for IBD.

The IBD Precision Medicine Research Program will bring together leading researchers, clinicians, and innovators across the country to develop tools that can transform how Crohn's disease and ulcerative colitis are diagnosed, treated, monitored, and ultimately prevented.

The program is focused on accelerating innovations such as:

A happy family playing with their young baby girl

Earlier diagnosis
Developing biomarker-based tests using blood, stool, and other biological samples that could help diagnose IBD faster and more accurately.

A physician speaking to her patient

Personalized treatment
Identifying genetic, microbial, and biological markers that help predict which medications will work best for each patient.

A young girl playing at being an airplane

Smarter disease monitoring
Using real-time patient data and digital health tools to detect changes earlier and guide treatment decisions before symptoms worsen.

A person tying their shoe and happy to be able to go outside and not feel like they need to stay in

Prevention and prediction
Advancing research that could identify people at highest risk of developing IBD and create interventions that prevent disease before it starts. 

Why it's about time

It's about time is more than a campaign. It's a rallying cry for everyone who believes people living with Crohn's and colitis deserve better.

For decades, progress in IBD care has not kept pace with the realities faced by patients.

It's about time to end try-and-fail treatments.

It's about time to make IBD more predictable.

It's about time to stop flare-ups before they start.

It's about time prevention changed the story for IBD.

Most of all, it's about time that people living with IBD get more time back for life.

Where people spend less time managing disease and more time living their lives.

It’s about time for precision medicine.